VANCOUVER, BRITISH COLUMBIA, CANADA, February 4, 2022 /EINPresswire.com/ -- iData Research, a global consulting and market research firm, has released exclusive research on the global interventional cardiology market, addressing key insights and the consequences of COVID-19 in 2020, 2021, and beyond. Despite a long-term trend of strong unit sales due to the prevalence of heart disease , COVID-19 had a negative impact on the interventional cardiology market largely caused by mass cancellations of non-urgent operations, including some surgeries for people with heart conditions. As a result, every region globally experienced low numbers for angiographies and angioplasties in 2020.
According to iData's Global Report for Interventional Cardiology, the global market covering 70 countries and 7 regions, was greatly affected by COVID-19. The pandemic resulted in a market decrease of 20% from 2019, reaching a valuation of $11.1 billion in 2020. However, the
interventional cardiology market started to recover in 2021, and is expected to continue on a positive trajectory of growth to reach an astonishing $16.2 billion by 2027. This report includes procedure volume, unit sales, average selling prices, market drivers and limiters, competitive market share analysis, and more.iData's analysis includes market analysis on coronary stents, coronary balloon catheters, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices, coronary atherectomy devices, introducer sheaths, coronary vascular closure devices (VCD), diagnostic coronary catheters & guidewires, coronary intravascular ultrasound (IVUS), and coronary optical coherency tomography.
Among the many competitors within these markets, Boston Scientific, Abbott Vascular, and Medtronic are the top three market share leaders. Boston Scientific was the leading competitor in the global market for interventional cardiology due to its presence in the coronary balloon catheter, coronary embolic protection device, and coronary atherectomy device market.
To accurately estimate market shares, units sold, average selling prices, product segments, and brands as well as procedural volumes, iData Research uses its proprietary market and procedure databases, as well as hospital purchase order data to complement its primary and secondary research initiatives.
Follow the link below to download a Free Research Summary of the Global Market Report for Interventional Cardiology. The full global report is also available for 10% off all licenses during American Heart Month.
https://idataresearch.com/product/interventional-cardiology-market/
For Further Information
More insights like this can be found in the latest reports by iData. Please email us at info@idataresearch.net or register online for a brochure and synopsis.
About iData
iData Research is an international consulting and market research firm dedicated to empowering confident strategic decisions within the medical device, dental, and pharmaceutical industries.
No comments:
Post a Comment